Dow Down0.48% Nasdaq Up0.29%

Momenta Pharmaceuticals Inc. (MNTA)

-NasdaqGS
11.78 Up 0.64(5.75%) May 31, 4:00PM EDT
|After Hours : 11.78 0.00 (0.00%) May 31, 4:36PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
Total Revenue 19,850   22,392   13,795   44,901  
Cost of Revenue -   -   -   -  
Gross Profit 19,850   22,392   13,795   44,901  
Operating Expenses
Research Development28,757  37,567  31,733  33,984  
Selling General and Administrative15,647  14,373  12,459  13,329  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (24,554) (29,548) (30,397) (2,412)
Income from Continuing Operations
Total Other Income/Expenses Net542  384  347  190  
Earnings Before Interest And Taxes(24,012)(29,164)(30,050)(2,222)
Interest Expense -   -   -   -  
Income Before Tax(24,012)(29,164)(30,050)(2,222)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(24,012)(29,164)(30,050)(2,222)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (24,012) (29,164) (30,050) (2,222)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (24,012) (29,164) (30,050) (2,222)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.